ENA NEWS: Patients with cancers of the gullet, stomach and bowel respond well to new anti-HER2 drug
New research published in European Cancer finds gastric cancer patients respond well to a new anti-HER2 drug, which binds to two distinct... Read More
Maintenance use of non-steroidal anti-inflammatory drugs and risk of gastrointestinal cancer in a nationwide population-based cohort study in Sweden
A new study via BMJ finds long-term use of low-dose aspirin and other non-selective non-steroidal anti-inflammatory drugs (NSAIDs) was associated with a... Read More
Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1
A new study shows possible clinical benefits of intraperitoneal paclitaxel for gastric cancer. Published in the Journal of Clinical Oncology, An American... Read More